Related Experiment Video
Updated: Feb 25, 2026
06:20
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
4.1K
Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity
Javier A Cienfuegos1, Fernando Rotellar2, Miguel Ruiz-Canela3
1Cirugía/ Apoyo Investigación, Clinica Universidad de Navarra, España.
Revista Espanola De Enfermedades Digestivas
|August 5, 2017
Abstract:
We thank Modesto Varas et al. for their opportune comments with regard to the oncologic outcomes of our series of patients undergoing surgery for a pancreatic neuroendocrine tumor. We agree Varas et al. with respect to the increase in nonfunctional tumors (73%) and the figures of the incidental form of presentation (44%), which are in line with those from most series.
